NCT00078260 - A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer | Biotech Hunter

Enrollment

589

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

April 30, 2008

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

pemetrexed

"A: 500 mg/m2, IV, q 21 days until disease progression~B: 900 mg/m2, IV, q 21 days until disease progression"

Trial Locations (2)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ankara

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Gaziantep